cancer vaccine

News

Merck gets on board with Moderna cancer vaccine in $250m dea...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million.

News

Targeting COVID-19 and cancer with immunotherapy advancements

RhoVac pummelled as lead cancer vaccine fails study

Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase 2b trial of its prostate

News

Nykode vaccine shows its worth in cervical cancer trial

Adding Nykode Therapeutics' VB10.16 vaccine to treatment with Roche's cancer immunotherapy Tecentriq resulted in disease control in two-thirds of patients with advanced cervical cancer.

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Imugene HER2 vaccine hits target in stomach cancer trial

A peptide vaccine developed by Australia's Imugene has reduced tumour size in around half of patients with HER2-positive gastric or gastroesophageal junction (GEJ) cancer in a phase 2 trial

News

BioNTech takes its first cancer vaccine into phase 2

It would be easy to forget that back in 2019, BioNTech was an early-stage biotech firmly focused on cancer vaccines, before being catapulted onto the world-stage with its COVID-19 shot.

News

Belgium's eTheRNA gets EU grant to develop mRNA cancer vacci...

Belgian immunotherapy firm eTheRNA has received a €6.9 million grant from the European Commission to accelerate clinical development of mRNA therapies for hard-to-treat cancers.

Merck gets on board with Moderna cancer vaccine in $250m dea...

RhoVac pummelled as lead cancer vaccine fails study

Nykode vaccine shows its worth in cervical cancer trial

Imugene HER2 vaccine hits target in stomach cancer trial

BioNTech takes its first cancer vaccine into phase 2

Belgium's eTheRNA gets EU grant to develop mRNA cancer vacci...

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

cancer vaccine

Editor's Picks